Series B - HEMO BIOENGINEERING

Series B - HEMO BIOENGINEERING

Investment Firm

Overview

HEMO BIOENGINEERING develops and provides innovative interventional medical devices to patients.

Announced Date

Oct 19, 2020

Funding Type

Series B

Highlights

Location

Asia

Social

Investor Lead

Hillhouse Ventures

Hillhouse Ventures

Hillhouse Ventures is a early_stage_venture firm.

Participant Investors

2

Investor Name
Participant InvestorHillhouse Ventures
Participant InvestorLegend Capital

Round Details and Background

HEMO BIOENGINEERING raised an undisclosed amount on 2020-10-19 in Series B

HEMO BIOENGINEERING develops and provides innovative interventional medical devices to patients.

Company Funding History

1

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Oct 19, 2020
Series B - HEMO BIOENGINEERING
3-undefined

Recent Activity

There is no recent news or activity for this profile.